EMBO Molecular Medicine

Papers
(The H4-Index of EMBO Molecular Medicine is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders353
Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture239
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer144
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies142
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis132
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis116
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions96
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability79
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking70
IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect68
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy67
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7 ‐deficient cells66
Flower lose, a cell fitness marker, predicts COVID‐19 prognosis63
Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐160
The state of the art of bispecific antibodies for treating human malignancies60
When fat meets the gut—focus on intestinal lipid handling in metabolic health and disease57
Elongator and the role of its subcomplexes in human diseases56
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C54
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia53
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo51
Systemic inflammation after stroke: implications for post‐stroke comorbidities51
Eosinophil‐derived IL ‐4 is necessary to establish the inflammatory structure in innate inflammation49
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain49
Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems49
Diagnostic biomarkers for active tuberculosis: progress and challenges48
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model47
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination46
Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies45
Nerve regeneration by interferon intervention in aging brain45
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy44
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer44
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers44
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration42
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis41
ALX1 ‐related frontonasal dysplasia results from defective neural crest cell development and migration40
In vivo single‐cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection40
Advances in high‐throughput mass spectrometry in drug discovery40
A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy39
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus39
0.17549204826355